Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier

J Immunol. 2001 Sep 1;167(5):2964-71. doi: 10.4049/jimmunol.167.5.2964.

Abstract

Chemokines are small chemotactic cytokines that modulate leukocyte recruitment and activation during inflammation. Here, we describe the role of macrophage inflammatory protein-1alpha (MIP-1alpha) during cuprizone intoxication, a model where demyelination of the CNS features a large accumulation of microglia/macrophage without T cell involvement or blood-brain barrier disruption. RNase protection assays showed that mRNA for numerous chemokines were up-regulated during cuprizone treatment in wild-type, C57BL/6 mice. RANTES, inflammatory protein-10, and monocyte chemoattractant protein-1 showed greatest expression with initiation of insult at 1-2 wk of treatment, whereas MIP-1alpha and beta increased later at 4-5 wk, coincident with peak demyelination and cellular accumulation. The function of MIP-1alpha during demyelination was tested in vivo by exposing MIP-1alpha knockout mice (MIP-1alpha(-/-)) to cuprizone and comparing pathology to wild-type mice. Demyelination at 3.5 wk of treatment was significantly decreased in MIP-1alpha(-/-) mice ( approximately 36% reduction), a result confirmed by morphology at the electron microscopic level. The delay in demyelination was correlated to apparent decreases in microglia/macrophage and astrocyte accumulation and in TNF-alpha protein levels. It was possible that larger effects of the MIP-1alpha deficiency were being masked by other redundant chemokines. Indeed, RNase protection assays revealed increased expression of several chemokine transcripts in both untreated and cuprizone-treated MIP-1alpha(-/-) mice. Nonetheless, despite this possible compensation, our studies show the importance of MIP-1alpha in demyelination in the CNS and highlight its effect, particularly on cellular recruitment and cytokine regulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Astrocytes / pathology
  • Blood-Brain Barrier / physiology
  • Chemokine CCL3
  • Chemokine CCL4
  • Chemokine CCL5 / genetics
  • Chemokines / genetics
  • Cuprizone / toxicity
  • Demyelinating Autoimmune Diseases, CNS / etiology*
  • Demyelinating Autoimmune Diseases, CNS / immunology
  • Demyelinating Autoimmune Diseases, CNS / pathology
  • Macrophage Inflammatory Proteins / deficiency*
  • Macrophage Inflammatory Proteins / genetics
  • Macrophage Inflammatory Proteins / physiology
  • Macrophages / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microglia / pathology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, Chemokine / genetics
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Up-Regulation / drug effects

Substances

  • Chemokine CCL3
  • Chemokine CCL4
  • Chemokine CCL5
  • Chemokines
  • Macrophage Inflammatory Proteins
  • RNA, Messenger
  • Receptors, Chemokine
  • Tumor Necrosis Factor-alpha
  • Cuprizone